Max Robotics — Global Service Robot Directory + US Certification

About

Christopher M. Tarnay is a leading figure in female pelvic medicine and reconstructive surgery, with a primary research focus on minimally invasive surgical treatments for pelvic organ prolapse (POP). His most impactful work includes a landmark randomized trial comparing robotic and laparoscopic sacrocolpopexy (259 citations), which provided critical evidence on outcomes and costs for these competing approaches. Tarnay has also pioneered innovative methods for surgical skill acquisition, notably through video-based peer feedback via social networking for robotic surgery simulation (49 citations). His expertise extends to the management of complex genitourinary fistulae, where he has authored comprehensive reviews on diagnostic techniques and evolving surgical approaches. Additionally, his case series on vaginal dehiscence after robotic-assisted radical cystectomy has informed safety protocols. As a co-investigator on the ACCESS clinical trial, Tarnay has contributed to comparative effectiveness research on endoscopic surgical strategies for apical prolapse, including analyses of port-site scar cosmesis. His work has been cited over 400 times, reflecting its influence on clinical practice and surgical training. Tarnay’s contributions have advanced the evidence base for robotic and laparoscopic techniques in urogynecology, benefiting both surgeons and patients.